Agios Pharmaceuticals (AGIO) reported Q4 revenue of $20 million, up from $10.7 million a year earlier.

Analysts polled by FactSet expected $12.1 million.

As of Dec. 31, the company had cash, cash equivalents and marketable securities of $1.2 billion.